相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Light-Triggered In Situ Gelation to Enable Robust Photodynamic-Immunotherapy by Repeated Stimulations
Zhouqi Meng et al.
ADVANCED MATERIALS (2019)
Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents
Chen Lossos et al.
CANCER DISCOVERY (2019)
Platelets as platforms for inhibition of tumor recurrence post-physical therapy by delivery of anti-PD-L1 checkpoint antibody
Xiao Han et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Adverse Events Following Cancer Immunotheraoy: Obstacles and Opportunities
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2019)
Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
Xiao Han et al.
SCIENCE ADVANCES (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression
Heng Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
Chao Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors
Tingting Wang et al.
NATURE COMMUNICATIONS (2018)
Immunotherapy after chemoradiotherapy in stage III non-small cell lung cancer: a new standard of care?
Anna W. Chalmers et al.
JOURNAL OF THORACIC DISEASE (2018)
Toward Biomaterials for Enhancing Immune Checkpoint Blockade Therapy
Qin Fan et al.
ADVANCED FUNCTIONAL MATERIALS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Hua Wang et al.
NATURE MATERIALS (2018)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Miguel F. Sanmamed et al.
CELL (2018)
Treg therapy in transplantation: a general overview
Marco Romano et al.
TRANSPLANT INTERNATIONAL (2017)
Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook
Chao Wang et al.
ADVANCED MATERIALS (2017)
Metronomic chemotherapy and immunotherapy in cancer treatment
Yu-Li Chen et al.
CANCER LETTERS (2017)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial
Vratislav Strnad et al.
LANCET (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Old-School Chemotherapy in Immunotherapeutic Combination in Cancer, A Low-cost Drug Repurposed
Rasha Abu Eid et al.
CANCER IMMUNOLOGY RESEARCH (2016)
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
K. Abiko et al.
BRITISH JOURNAL OF CANCER (2015)
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK
Idit Sagiv-Barfi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Leisha A. Emens et al.
CANCER IMMUNOLOGY RESEARCH (2015)
An Imagable and Photothermal Abraxane-Like Nanodrug for Combination Cancer Therapy to Treat Subcutaneous and Metastatic Breast Tumors
Qian Chen et al.
ADVANCED MATERIALS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Biopolymer implants enhance the efficacy of adoptive T-cell therapy
Sirkka B. Stephan et al.
NATURE BIOTECHNOLOGY (2015)
Immunological Responses Triggered by Photothermal Therapy with Carbon Nanotubes in Combination with Anti-CTLA-4 Therapy to Inhibit Cancer Metastasis
Chao Wang et al.
ADVANCED MATERIALS (2014)
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
L. Bracci et al.
CELL DEATH AND DIFFERENTIATION (2014)
Fibrin-based scaffold incorporating VEGF- and bFGF-loaded nanoparticles stimulates wound healing in diabetic mice
Paola Losi et al.
ACTA BIOMATERIALIA (2013)
Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy
Mariana S. Nars et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Cyclophosphamide Promotes Chronic Inflammation-Dependent Immunosuppression and Prevents Antitumor Response in Melanoma
Alexandra Sevko et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Chemotherapy in epithelial ovarian cancer
Sandro Pignata et al.
CANCER LETTERS (2011)
Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
Giovanna Schiavoni et al.
CANCER RESEARCH (2011)
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
Kristin M. Nieman et al.
NATURE MEDICINE (2011)
Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
W. M. Liu et al.
BRITISH JOURNAL OF CANCER (2010)
Immunogenic chemotherapy with cyclophosphamide and doxorubicin against established murine carcinoma
Miki Tongu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Chemopreventive agents induce programmed death-1-ligand 1 (PD-L1) surface expression in breast cancer cells and promote PD-L1-mediated T cell apoptosis
Ping Zhang et al.
MOLECULAR IMMUNOLOGY (2008)
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer
Junzo Hamanishi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
分享论文
